Table 2

The relationship between Wnt-5a expression and other clinicopathological features (1980/85)

No.Weak (+/−)Normal (+++/++)
Patients with recurrence
 Age
  <5032 (67%)1 (33%)
  ≥502923 (79%)6 (21%)
 Histological grade
  I77 (100%)0 (0%)
  II73 (43%)4 (57%)
  III1815 (83%)3 (17%)
 Tumor Size
  T1 ≤ 20 mm1411 (79%)3 (21%)
  T2 >20 ≤ 50 mm1512 (80%)3 (20%)
  T3 > 50 mm32 (67%)1 (23%)
 Lymph node statusa
  Negative87 (87%)1 (13%)
  Positive1814 (78%)4 (22%)
Recurrence-free patients
 Age
  <50106 (60%)4 (40%)
  ≥504112 (29%)29 (71%)
 Histological grade
  I94 (44%)5 (56%)
  II143 (21%)11 (79%)
  III2811 (39%)17 (61%)
 Tumor Size
  T1 ≤ 20 mm338 (24%)25 (76%)
  T2 > 20 ≤ 50 mm1810 (56%)8 (44%)
  T3 > 50 mm0
 Lymph node statusb
  Negative3312 (36%)21 (64%)
  Positive135 (38%)8 (62%)
  • a Data available for 26 of 32 patients.

  • b Data available for 46 of 51 patients.